Evergreen Therapeutics, Inc.
PrivateLast Round
Series A
Extension
Jun 17, 2024
Total Funding Raised
$15M
Company Overview
Evergreen Therapeutics, Inc. is a biotechnology company that develops novel drug candidates for unmet medical needs using an AI-powered drug discovery and development platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evergreen Therapeutics, Inc. Comparables
Compare Evergreen Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Artivila Biopharma | 88% | |
| Genesis Therapeutics | 80% | |
| MindRank | 79% | |
Evergreen Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 17, 2024 | ||||
| Series A | Mar 1, 2021 | ||||
| Angel | Mar 16, 2020 |
Key People
Founding team and executive leadership
Evergreen Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tiantu Capital | Series A |
| Share Capital | Angel |
| SB China Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Monthly visitors increased 141% MoM.
- Jun 17, 2024
Raised Series A Extension with SB China Capital and Yantai Biomedical Health Industry Development Parent Fund.
Evergreen Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Evergreen Therapeutics, Inc.'s valuation, stock price, and market status.